ATOSSA THERAPEUTICS, INC. Earnings Per Share, Basic and Diluted
ATOSSA THERAPEUTICS, INC. (ATOS) reported Earnings Per Share, Basic and Diluted of -$0.18 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-28.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-02-28
- ATOSSA THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2021-12-31 was $0.01, a 96.63% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.04.
- ATOSSA THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.06.
- ATOSSA THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.04.
- ATOSSA THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2021 was -$0.18.
- ATOSSA THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2020 was -$1.97.
- ATOSSA THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2019 was -$2.03.
- ATOSSA THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2018 was -$5.50.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed | Earnings Per Share, Basic and Diluted 41 month | Earnings Per Share, Basic and Diluted 44 month | Earnings Per Share, Basic and Diluted 47 month | Earnings Per Share, Basic and Diluted 50 month | Earnings Per Share, Basic and Diluted 53 month | Earnings Per Share, Basic and Diluted 56 month | Earnings Per Share, Basic and Diluted 59 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | $0.01 derived: net income ÷ weighted average shares · filed 2022-02-28 | $0.09 derived: net income ÷ weighted average shares · filed 2022-11-07 | $0.55 derived: net income ÷ weighted average shares · filed 2022-11-07 | -$0.18 10-K · filed 2022-02-28 | |||||||||||
| 2021-09-30 | -$0.04 10-Q · filed 2021-11-15 | -$0.10 derived: net income ÷ weighted average shares · filed 2022-11-07 | -$0.14 10-Q · filed 2021-11-15 | -$0.36 derived: net income ÷ weighted average shares · filed 2022-11-07 | |||||||||||
| 2021-06-30 | -$0.06 10-Q · filed 2021-08-13 | -$0.10 10-Q · filed 2021-08-13 | -$0.36 derived: net income ÷ weighted average shares · filed 2022-08-08 | -$0.53 derived: net income ÷ weighted average shares · filed 2022-08-08 | |||||||||||
| 2021-03-31 | -$0.04 10-Q · filed 2021-05-14 | -$0.48 derived: net income ÷ weighted average shares · filed 2022-05-09 | -$0.77 derived: net income ÷ weighted average shares · filed 2022-05-09 | -$1.10 derived: net income ÷ weighted average shares · filed 2022-05-09 | |||||||||||
| 2020-12-31 | $0.42 derived: net income ÷ weighted average shares · filed 2022-02-28 | $1.69 derived: net income ÷ weighted average shares · filed 2022-02-28 | $6.40 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$1.97 10-K · filed 2022-02-28 | |||||||||||
| 2020-09-30 | -$0.34 10-Q · filed 2021-11-15 | -$0.76 derived: net income ÷ weighted average shares · filed 2021-11-15 | -$1.09 10-Q · filed 2021-11-15 | -$1.38 derived: net income ÷ weighted average shares · filed 2021-11-15 | |||||||||||
| 2020-06-30 | -$0.43 10-Q · filed 2021-08-13 | -$0.75 10-Q · filed 2021-08-13 | -$1.03 derived: net income ÷ weighted average shares · filed 2021-08-13 | -$1.39 derived: net income ÷ weighted average shares · filed 2021-08-13 | |||||||||||
| 2020-03-31 | -$0.32 10-Q · filed 2021-05-14 | -$0.61 derived: net income ÷ weighted average shares · filed 2021-05-14 | -$0.97 derived: net income ÷ weighted average shares · filed 2021-05-14 | -$1.76 derived: net income ÷ weighted average shares · filed 2021-05-14 | |||||||||||
| 2019-12-31 | -$0.29 derived: net income ÷ weighted average shares · filed 2021-03-31 | -$0.65 derived: net income ÷ weighted average shares · filed 2021-03-31 | -$1.44 derived: net income ÷ weighted average shares · filed 2021-03-31 | -$2.03 10-K · filed 2021-03-31 | |||||||||||
| 2019-09-30 | -$0.36 10-Q · filed 2020-11-13 | -$1.16 derived: net income ÷ weighted average shares · filed 2020-11-13 | -$1.77 10-Q · filed 2020-11-13 | -$2.19 derived: net income ÷ weighted average shares · filed 2020-11-13 | |||||||||||
| 2019-06-30 | -$0.80 10-Q · filed 2020-08-13 | -$1.44 10-Q · filed 2020-08-13 | -$1.88 derived: net income ÷ weighted average shares · filed 2020-08-13 | -$2.52 derived: net income ÷ weighted average shares · filed 2020-08-13 | |||||||||||
| 2019-03-31 | -$0.62 10-Q · filed 2020-05-13 | -$1.00 derived: net income ÷ weighted average shares · filed 2020-05-13 | -$1.63 derived: net income ÷ weighted average shares · filed 2020-05-13 | -$4.89 derived: net income ÷ weighted average shares · filed 2020-05-13 | |||||||||||
| 2018-12-31 | -$0.36 derived: net income ÷ weighted average shares · filed 2020-03-26 | -$0.99 derived: net income ÷ weighted average shares · filed 2020-03-26 | -$4.52 derived: net income ÷ weighted average shares · filed 2020-03-26 | -$5.50 10-K · filed 2020-03-26 | |||||||||||
| 2018-09-30 | -$0.64 10-Q · filed 2019-11-13 | -$4.59 derived: net income ÷ weighted average shares · filed 2019-11-13 | -$5.71 10-Q · filed 2019-11-13 | -$8.76 derived: net income ÷ weighted average shares · filed 2019-11-13 | |||||||||||
| 2018-06-30 | -$5.08 10-Q · filed 2019-08-13 | -$2.90 10-Q · filed 2018-08-13 | -$6.11 10-Q · filed 2019-08-13 | -$3.77 10-Q · filed 2018-08-13 | -$11.20 derived: net income ÷ weighted average shares · filed 2019-08-13 | -$13.86 derived: net income ÷ weighted average shares · filed 2019-08-13 | |||||||||
| 2018-03-31 | -$8.48 10-Q · filed 2019-05-13 | -$0.71 10-Q · filed 2018-05-14 | -$3.60 derived: net income ÷ weighted average shares · filed 2019-05-13 | -$5.70 derived: net income ÷ weighted average shares · filed 2019-05-13 | -$11.42 derived: net income ÷ weighted average shares · filed 2019-05-13 | ||||||||||
| 2017-12-31 | -$1.03 derived: net income ÷ weighted average shares · filed 2019-03-28 | -$2.82 derived: net income ÷ weighted average shares · filed 2019-03-28 | -$7.52 derived: net income ÷ weighted average shares · filed 2019-03-28 | -$10.97 10-K · filed 2019-03-28 | -$0.91 10-K · filed 2018-03-08 | ||||||||||
| 2017-09-30 | -$2.11 10-Q · filed 2018-11-14 | -$0.18 10-Q · filed 2017-11-13 | -$8.44 derived: net income ÷ weighted average shares · filed 2018-11-14 | -$13.23 10-Q · filed 2018-11-14 | -$1.10 10-Q · filed 2017-11-13 | ||||||||||
| 2017-06-30 | -$7.72 10-Q/A · filed 2018-11-13 | -$0.64 10-Q · filed 2017-08-14 | -$13.85 10-Q/A · filed 2018-11-13 | -$1.15 10-Q · filed 2017-08-14 | |||||||||||
| 2017-03-31 | -$5.40 10-Q · filed 2018-05-14 | -$0.45 10-Q · filed 2017-05-11 | |||||||||||||
| 2016-12-31 | -$0.67 derived: net income ÷ weighted average shares · filed 2018-03-08 | -$0.68 derived: net income ÷ weighted average shares · filed 2018-03-08 | -$1.29 derived: net income ÷ weighted average shares · filed 2018-03-08 | -$2.16 10-K · filed 2018-03-08 | -$2.80 10-K · filed 2017-03-16 | ||||||||||
| 2016-09-30 | $0.07 10-Q · filed 2017-11-13 | -$0.54 derived: net income ÷ weighted average shares · filed 2017-11-13 | -$1.44 10-Q · filed 2017-11-13 | ||||||||||||
| 2016-06-30 | -$0.67 10-Q · filed 2017-08-14 | -$0.05 10-Q · filed 2016-08-12 | -$1.63 10-Q · filed 2017-08-14 | -$0.12 10-Q · filed 2016-08-12 | |||||||||||
| 2016-03-31 | -$0.98 10-Q · filed 2017-05-11 | -$0.07 10-Q · filed 2016-05-05 | |||||||||||||
| 2015-12-31 | -$8.31 10-K/A · filed 2017-03-21 | -$0.55 10-K · filed 2016-03-30 | |||||||||||||
| 2015-09-30 | -$0.15 10-Q · filed 2015-11-12 | -$0.39 10-Q · filed 2015-11-12 | |||||||||||||
| 2015-06-30 | -$0.11 10-Q/A · filed 2017-03-21 | -$0.25 10-Q/A · filed 2017-03-21 | |||||||||||||
| 2015-03-31 | -$0.13 10-Q/A · filed 2017-03-21 | ||||||||||||||
| 2014-12-31 | -$0.61 10-K · filed 2016-03-30 | ||||||||||||||
| 2014-09-30 | -$0.13 10-Q · filed 2015-11-12 | -$0.37 10-Q · filed 2015-11-12 | |||||||||||||
| 2014-06-30 | -$0.13 10-Q · filed 2015-08-06 | -$0.23 10-Q · filed 2014-08-12 | -$0.24 10-Q · filed 2015-08-06 | ||||||||||||
| 2014-03-31 | -$0.10 10-Q · filed 2015-05-13 | -$2.16 10-Q · filed 2014-05-14 | |||||||||||||
| 2013-12-31 | -$0.70 10-K · filed 2015-03-30 | -$2.14 10-K · filed 2014-03-27 | |||||||||||||
| 2013-09-30 | -$0.22 10-Q · filed 2014-11-12 | -$0.55 10-Q · filed 2014-11-12 | -$1.95 10-Q · filed 2013-11-12 | ||||||||||||
| 2013-06-30 | -$0.17 10-Q · filed 2014-08-12 | -$0.32 10-Q · filed 2014-08-12 | -$1.63 10-Q · filed 2013-08-14 | ||||||||||||
| 2013-03-31 | -$0.14 10-Q · filed 2014-05-14 | -$1.36 10-Q · filed 2013-05-15 | |||||||||||||
| 2012-12-31 | -$0.41 10-K · filed 2014-03-27 | -$1.27 10-K · filed 2013-03-28 | |||||||||||||
| 2012-09-30 | -$0.10 10-Q · filed 2013-11-12 | -$0.30 10-Q · filed 2013-11-12 | -$1.05 10-Q/A · filed 2013-01-22 | ||||||||||||
| 2012-06-30 | -$0.10 10-Q · filed 2013-08-14 | -$0.20 10-Q · filed 2013-08-14 | |||||||||||||
| 2012-03-31 | -$0.09 10-Q · filed 2013-05-15 | ||||||||||||||
| 2011-12-31 | -$0.38 10-K · filed 2013-03-28 | ||||||||||||||
| 2011-09-30 | -$0.11 10-Q/A · filed 2013-01-22 | -$0.27 10-Q/A · filed 2013-01-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |